Newsquawk Rundown, Daily Podcast

European bourses trade mixed but off worse levels, with sectors not displaying a clear risk profileUK has approved the Pfizer (PFE)/ BioNTech (BNTX) COVID-19 vaccine, which will be available across the UK from next weekUS President-elect Biden will not immediately remove phase one tariffs on China according to a NYT Op-Ed citing a phone call with BidenSticking points in Brexit talks, a deal still hangs in the balance, according to a...

Asia-Pac stocks lacked firm direction as momentum faded from the record-setting performance on Wall St, where the S&P 500 and Nasdaq printed fresh all-time highsUS President-elect Biden will not immediately remove phase one tariffs on China according to a NYT Op-Ed citing a phone call with BidenIn FX markets, the DXY remains sub 91.50, EUR/USD gained a firmer footing above 1.20 and GBP/USD plateaued above 1.34Initial reports suggested...

Major European bourses see gains across the board with US equity futures also in firm positive territoryEMA has received application for conditional market authorisation for Pfizer/BioNTech's and Moderna's vaccine candidatesFed Chair Powell’s testimony at the Senate Banking Committee reiterated that the outlook for the US economy is uncertain and will depend on the virusECB's Schnabel says the ECB is not obliged to do what the market...

Asian equity markets traded positively as strong data releases helped the region shrug-off the weak handover from US where stocks were pressured by month-end flowsChinese Caixin Manufacturing PMI data printed at a decade high of 54.9 vs. Exp. 53.5 and spurred Chinese markets to pick up from the slow startThe RBA kept policy settings unchanged as expected and provided a balanced view of the economyIn FX, the DXY pulled back from 92.00,...

European stocks see a mixed picture following a lacklustre open, with no risk profile to be derived from sectorsEU is reportedly seeking a new alliance with US to bury the tensions and to meet the new challenges related to ChinaUK could grant approval to Pfizer and BioNTech's vaccine within days; EMA is set to consider approval of Pfizer/BioNTech vaccine next month and will also consider Moderna’s vaccineEuropean Commission is reportedly...

Asian equity markets began the week mixed amid tentativeness heading into month-end and upcoming key risk eventsThe region also digesting a slew of data including better than expected Chinese Manufacturing and Non-Manufacturing PMI dataUK is set to become the first western country to approve a COVID-19 vaccine in which the regulator could grant approval to Pfizer and BioNTech's vaccine within daysThe DXY extended its retreat below 92.00...

European indices have posted mixed performance with US futures modestly positive though RTY -0.2% lags slightly with overall magnitudes relatively containedDXY has continued to drift but remains above the YTD low of 91.740, with major peers generally firmer but with limited conviction in thin liquidity; though GBP was impacted in a delayed reaction to Barnier remarksEU Chief Brexit Negotiator Barnier says he is travelling to London this evening to...

Asian equity markets were mixed as trade continued to lack firm direction following the holiday closure in the US for ThanksgivingThe AstraZeneca/Oxford University vaccine is set to undergo a new global trial to appease critics questioning the claim that the vaccine can protect up to 90% of people against COVID-19In FX, the DXY trades sub 92.00, GBP/USD is unable to breach 1.34 thus far and EUR/USD maintains 1.19 statusUK and EU are set...

Post-Fed minutes, some kind of action seems likely in December; what exact action will be taken remains to be seen, given the minutes had something for everyoneA non-committal tone was evident for most of Asia-Pac trade following the indecisive lead from the US where stocks were rangebound heading into the Thanksgiving holidayIn FX markets, the DXY was lacklustre beneath 92.00, EUR/USD held 1.19 status and GBP/USD eyed 1.34 to the...

European indices are softer with cyclicals marginally underperforming thus far, Euro Stoxx 50 -0.3%; a similar theme is evident in US futures with the RTY -0.4% underperforming the NQ +0.2% thus farFX has seen the USD pick-up throughout the morning as equity sentiment continues to slip with major peers mixed/subdued against the USD itselfChina is likely to approve a COVID-19 vaccine by year-end to meet the need of epidemic-stricken countries, Global Times citing...